Log In
No results found for "".

Commentary & Deal Flow

NEW ISSUE: The Procter & Gamble Company € bmk 4yr, 8yr, 12yr & 20yr Sr Unsec; MS+65a & MS+95a & MS+115a & MS+145a

IGC European Market: Deal Flow - General

Issuer

Term

Maturity

Size

Ranking

Type

IPT

ISIN

The Procter & Gamble Company

4yr

03-Nov-30

bmk

Sr Unsec

Fixed

MS+65a

XS3553990360

The Procter & Gamble Company

8yr

03-Nov-34

bmk

Sr Unsec

Fixed

MS+95a

XS3553990444

The Procter & Gamble Company

12yr

03-Nov-38

bmk

Sr Unsec

Fixed

MS+115a

XS3553990527

The Procter & Gamble Company

20yr

03-Nov-46

bmk

Sr Unsec

Fixed

MS+145a

XS3553990790


IPTs: 4yr: MS+65a 8yr: MS+95a 12yr: MS+115a 20yr: MS+145a


  • Issuer: The Procter & Gamble Company
  • Ticker: PG
  • LEI: 2572IBTT8CCZW6AU4I41
  • Expected Ratings: Aa3 (Positive) / AA- (Stable) (Moody's/S&P)
  • Format: Senior Unsecured Notes
  • Pricing Date: 27-Oct-26
  • Settlement: 03-Nov-26 (T+5)
  • Size: € Benchmark (each tranche)
  • Maturity:
    • 4yr: 03-Nov-30
    • 8yr: 03-Nov-34
    • 12yr: 03-Nov-38
    • 20yr: 03-Nov-46
  • Coupon: Fixed, Annual, ACT/ACT (ICMA) for all tranches
  • Optional Redemption: MWC for all tranches
  • ISIN / Common Code:
    • 4yr: XS3553990360 / 355399036
    • 8yr: XS3553990444 / 355399044
    • 12yr: XS3553990527 / 355399052
    • 20yr: XS3553990790 / 355399079
  • B&D: DB for all tranches
  • Timing: Books open, Today's business
  • Joint Book-Running Managers: Citi / DB (B&D) / GS / HSBC / MS
  • Target Market: MiFID II and UK MiFIR professionals / ECPs-only / No PRIIPs KID or DISC Disclosure Document
  • Stabilization: FCA / ICMA
  • Selling Restrictions: As per The Procter & Gamble Companys Preliminary Prospectus Supplement
  • Clearing: Euroclear and Clearstream
  • Docs: SEC Registered / New York Stock Exchange Listing / New York Law
  • Denominations: €100,000 x €1,000
  • UoP: General Corporate Purposes